CHRIS AMOS to ROC Curve
This is a "connection" page, showing publications CHRIS AMOS has written about ROC Curve.
Connection Strength
0.407
-
A Novel Pathway-Based Approach Improves Lung Cancer Risk Prediction Using Germline Genetic Variations. Cancer Epidemiol Biomarkers Prev. 2016 08; 25(8):1208-15.
Score: 0.105
-
Assessing BRCA carrier probabilities in extended families. J Clin Oncol. 2006 Jan 20; 24(3):354-60.
Score: 0.051
-
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. Clin Cancer Res. 2025 Dec 15; 31(24):5225-5236.
Score: 0.051
-
Genetic variants of SDCCAG8 and MAGI2 in mitosis-related pathway genes are independent predictors of cutaneous melanoma-specific survival. Cancer Sci. 2021 Oct; 112(10):4355-4364.
Score: 0.038
-
Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer. 2018 06 01; 142(11):2303-2312.
Score: 0.030
-
Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival. Int J Cancer. 2015 Aug 01; 137(3):638-45.
Score: 0.024
-
Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. J Invest Dermatol. 2015 Feb; 135(2):542-550.
Score: 0.023
-
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2012 May; 133(1):347-55.
Score: 0.020
-
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25.
Score: 0.018
-
Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2009 Dec 16; 101(24):1731-2; author reply 1732.
Score: 0.017
-
Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol. 2007 Nov 01; 25(31):4974-81.
Score: 0.015
-
BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol. 2007 Oct 10; 25(29):4635-41.
Score: 0.014